San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, CERo Therapeutics is raising $43,249,966.00 in new funding. Sources indicate as part of senior management Founder, Daniel Corey played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CERo Therapeutics

CERo Therapeutics is a well capitalized cellular immunotherapy company developing next generation therapies located in San Francisco at the Jlabs biotechnology incubator. CERo Therapeutics, Inc. is a new cellular immunotherapy company. We have created a hybrid platform that integrates innate and adaptive programs to eliminate disease. We invite talented and passionate industry professionals to join us as we grow to become a leading cellular immunotherapy company.

To learn more about CERo Therapeutics, visit http://www.cero.bio/

Contact:
Daniel Corey, Founder
650-491-9600
dcorey@cero.bio
https://www.linkedin.com/in/daniel-corey-md-761411130/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved